Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia
Year: 2026
Type: article
Abstract: BACKGROUND: In low-resource facilities that routinely use intrapartum prophylactic antimicrobials, the use of multiple antimicrobials could be rationalised by a single oral dose of oral azithromycin. METHODS: The Azithromycin Prevention in Labor Use Study (A-PLUS), a randomized double-blind, placebo-controlled trial performed across eight sites in seven countries amongst women who planned to deliver vaginally. They were randomly assigned to receive study drug, a single intrapartum 2 gm oral dose of azithromycin or an identical appearing placebo. Data from four South-East Asia sites (Indian sites Nagpur and Belagavi, Pakistan, and Bangladesh) was analyzed to evaluate whether the use of non-study antimicrobials (alone or in-combination) given after randomization through one-day postpartum for any indication (prophylactic or treatment) modified the effect of study drugs on maternal outcomes (maternal infections, antibiotic usage 2-42days postpartum on ambulatory basis or re-hospitalization). The non-study antimicrobials given after randomization through 1-day postpartum was defined by four exposure sub-groups within azithromycin and placebo arm as, Use of: i) No non-study antibiotic; ii) Cephalosporin only; iii) Other non-study non-cephalosporin antibiotics; and iv) Cephalosporin and other non-study non-cephalosporin antibiotics. An intent to treat (ITT) analysis was adopted. Adjusted relative risks and 95% confidence intervals comparing azithromycin with placebo were estimated using Poisson regression models with robust variance estimators that included study site, maternal non-study antimicrobial use, and a treatment-by-non-study antimicrobial use interaction term. RESULTS: All maternal non-study antibiotic subgroups had balanced randomization between azithromycin and placebo. The risk of any maternal infections was reduced when only azithromycin was received versus placebo (RR = 0.75; 95% CI-0.57-0.98) and when group iv antimicrobials were used with azithromycin compared to only group iv antimicrobials (RR = 0.79; 95% CI-0.66-0.95). The use of antibiotics from day2-42 was similar in both arms (azithromycin or placebo) with or without use of other antimicrobials. CONCLUSIONS: This secondary analysis found no evidence that non-study antimicrobials use modified the effect of azithromycin on maternal outcomes. This study underscores the importance of considering an easily administrable intrapartum prophylaxis of oral monotherapy in low resource, high risk for infections sites to reduce antimicrobial resistance due to multiple antimicrobial use.
Source: PLoS ONE
Authors: Archana B. Patel(Conceptualization, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing), Kunal Kurhe(Investigation, Supervision, Writing – review & editing), Savita Bhargav(Investigation, Supervision, Writing – review & editing), Vaishali Khedikar(Investigation, Project administration, Writing – review & editing), Manjushri Waikar(Investigation, Project administration, Writing – review & editing), Poonam Shivkumar(Investigation, Project administration, Writing – review & editing), Shivaprasad S. Goudar(Investigation, Project administration, Writing – review & editing), Mrityunjay C. Metgud(Investigation, Project administration, Writing – review & editing), Avinash Kavi(Investigation, Supervision, Writing – review & editing), Richard Derman(Investigation, Project administration, Writing – review & editing), Rashidul Haque(Investigation, Project administration, Writing – review & editing), Sk Masum Billah(Investigation, Project administration, Writing – review & editing), William Petri(Investigation, Project administration, Writing – review & editing), Sarah Saleem(Investigation, Project administration, Writing – review & editing), Saleem Jessani(Investigation, Project administration, Writing – review & editing), Shiyam Sunder Tikmani(Investigation, Supervision, Writing – review & editing), Robert L. Goldenberg(Investigation, Project administration, Writing – review & editing), Jennifer J. Hemingway-Foday(Data curation, Project administration, Software, Writing – review & editing), Marion Koso-Thomas(Funding acquisition, Resources, Writing – review & editing), Alan T. N. Tita(Investigation, Project administration, Writing – review & editing), Waldemar A. Carlo(Investigation, Project administration, Writing – review & editing), Janet L. Moore(Data curation, Formal analysis, Methodology, Writing – review & editing), Denise C. Babineau(Data curation, Formal analysis, Methodology, Writing – review & editing), Eleanor Nielsen(Data curation, Formal analysis, Writing – original draft, Writing – review & editing), Elizabeth M. McClure(Formal analysis, Investigation, Resources, Validation, Writing – review & editing), Patricia L. Hibberd(Conceptualization, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing)
Institutions: Lata Medical Research Foundation, Government Medical College, Mahatma Gandhi Institute of Medical Sciences, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research, Thomas Jefferson University, International Centre for Diarrhoeal Disease Research, The University of Sydney, University of Virginia, Aga Khan University, Columbia University, RTI International, Eunice Kennedy Shriver National Institute of Child Health and Human Development, University of Alabama at Birmingham, Boston University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: Foundation for the National Institutes of Health (FNIH) - to assess the efficacy of intrapartum delivery of azithromycin in reducing neonatal and maternal sepsis/mortality in South Asia and Sub Saharan Africa, TJU-JNMC Global Network for Women's and Children's Health Research Unit, NICHD Global Network for Women’s and Children’s Health Research: Research Units, Global Network for Women's and Children's Health Research Data Coordinating Center, Boston University/Lata Medical Research Foundation Global Network for Women's Children's Health Research Unit, Columbia University/Aga Khan University Global Network Research Unit
OpenAlex ID: W7236257371
